abzyme_gr

E-vaccine has the potential to prevent HIV infection or to treat humans infected with HIV. The Abzyme Research Foundation's mission is to facilitate scientific and medical collaborations among leaders in the HIV field drawn from non-profit and for-profit organizations... READ MORE

Current News & Articles

Special Recent Posts

No thumbnail available

Interview With Dr. Elizabeth Miller

To start with, tell me about your current work at Mount Sinai: I work in the field of therapeutic vaccines for HIV infection. The goal of these vaccines is to help the immune systems’ of HIV-infected...[Read MORE]

2013 Annual Report

2013 Annual Report

2013 was a fantastic year for the Abzyme Research Foundation and our research partners Covalent Bioscience. With guidance from our incredible FDA regulatory consultant, Dr. Ellen Cooper, Dr. Sudhir ...[Read MORE]

No thumbnail available

Progress Towards A Human Trial

Explore the research and developmental steps of the HIV vaccine approach created by Dr. Sudhir Paul and Covalent Bioscience.  Below is a spreadsheet that aligns the specific developments aligned with ...[Read MORE]

Meet Our New Board Members

Meet Our New Board Members

Fresh Perspectives Abzyme Research Foundation is proud to announce two new board members. Brian DeLaurentis is a skilled attorney with a specialty in financial transactions. It is due to his knowled...[Read MORE]

Our FDA Pre-IND Date is 4/2/14

Our FDA Pre-IND Date is 4/2/14

Do you know what it takes to get a new HIV vaccine into human trials?  The process involves scientists, the FDA, manufacturers, trial sites and significant resources. This edition of the #ENDHIV ne...[Read MORE]